C030:XETRA:XETRA-Amundi Index Solutions - Amundi DJ Switzerland Titans 30 UCITS ETF CHF Distributing EUR (EUR)

ETF | Others |

Last Closing

USD 165.96

Change

+2.02 (+1.23)%

Market Cap

USD 0.13B

Volume

426.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.20 (+0.39%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.07 (+0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.38%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.56 (+0.39%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.20 (+0.38%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.07 (+0.06%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.18 (-0.03%)

USD 80.38B

ETFs Containing C030:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.00% 85% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.00% 85% B 81% B-
Trailing 12 Months  
Capital Gain 14.05% 53% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.05% 52% F 55% F
Trailing 5 Years  
Capital Gain 35.74% 61% D- 64% D
Dividend Return 6.59% 39% F 30% F
Total Return 42.33% 63% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 9.15% 61% D- 61% D-
Dividend Return 9.66% 62% D 60% D-
Total Return 0.51% 47% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 10.73% 60% D- 68% D+
Risk Adjusted Return 90.06% 79% B- 82% B
Market Capitalization 0.13B 38% F 34% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.